- Home
- JOB vs PMN Comparison
JOB vs PMN Comparison
Compare JOB & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- PMN
- Stock Information
- Founded
- JOB 1893
- PMN 2004
- Country
- JOB United States
- PMN Canada
- Employees
- JOB N/A
- PMN N/A
- Industry
- JOB Diversified Commercial Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- JOB Consumer Discretionary
- PMN Health Care
- Exchange
- JOB Nasdaq
- PMN Nasdaq
- Market Cap
- JOB 22.5M
- PMN 23.5M
- IPO Year
- JOB N/A
- PMN N/A
- Fundamental
- Price
- JOB $0.18
- PMN $0.44
- Analyst Decision
- JOB
- PMN Strong Buy
- Analyst Count
- JOB 0
- PMN 3
- Target Price
- JOB N/A
- PMN $4.00
- AVG Volume (30 Days)
- JOB 390.7K
- PMN 498.0K
- Earning Date
- JOB 12-18-2025
- PMN 11-12-2025
- Dividend Yield
- JOB N/A
- PMN N/A
- EPS Growth
- JOB N/A
- PMN N/A
- EPS
- JOB N/A
- PMN N/A
- Revenue
- JOB $108,752,000.00
- PMN N/A
- Revenue This Year
- JOB $43.94
- PMN N/A
- Revenue Next Year
- JOB N/A
- PMN N/A
- P/E Ratio
- JOB N/A
- PMN N/A
- Revenue Growth
- JOB N/A
- PMN N/A
- 52 Week Low
- JOB $0.17
- PMN $0.35
- 52 Week High
- JOB $0.51
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- JOB 42.27
- PMN 51.56
- Support Level
- JOB $0.19
- PMN $0.36
- Resistance Level
- JOB $0.19
- PMN $0.45
- Average True Range (ATR)
- JOB 0.01
- PMN 0.04
- MACD
- JOB 0.00
- PMN 0.00
- Stochastic Oscillator
- JOB 25.21
- PMN 69.31
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.